Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Bell

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
European Journal of Pharmacology|October 7, 2004
Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screeningPeter J Craig, Suchira Bose, Ruud Zwart, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2025
Innate immune response to AAV-based gene therapy vectors: Mechanisms of complement activation and cytokine releaseRebecca Xicluna, Petra C Schwalie, Emma Bell, et al.
Development (Cambridge, England)|January 15, 2017
Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiationRute A Tomaz, Jennifer L Harman, Donja Karimlou, et al.
Cancer Research|September 17, 2016
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Sebastian Bender, Maral Saadati, et al.
Structure (London, England : 1993)|February 9, 2005
dUTPase as a platform for antimalarial drug design: structural basis for the selectivity of a class of nucleoside inhibitorsJean L Whittingham, Isabel Leal, Corinne Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Targeting MYCN-Driven Transcription By BET-Bromodomain InhibitionAnton Henssen, Kristina Althoff, Andrea Odersky, et al.
Molecular Cell|February 20, 2021
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> T cellsHelen Loo Yau, Emma Bell, Ilias Ettayebi, et al.
Nature Cancer|February 19, 2026
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detectionYong Zeng, Dor D Abelman, Althaf Singhawansa, et al.
Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.
Nature|October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Falk Hertwig, Frederik Roels, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
European Journal of Pharmacology|October 7, 2004
Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screeningPeter J Craig, Suchira Bose, Ruud Zwart, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2025
Innate immune response to AAV-based gene therapy vectors: Mechanisms of complement activation and cytokine releaseRebecca Xicluna, Petra C Schwalie, Emma Bell, et al.
Development (Cambridge, England)|January 15, 2017
Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiationRute A Tomaz, Jennifer L Harman, Donja Karimlou, et al.
Cancer Research|September 17, 2016
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Sebastian Bender, Maral Saadati, et al.
Structure (London, England : 1993)|February 9, 2005
dUTPase as a platform for antimalarial drug design: structural basis for the selectivity of a class of nucleoside inhibitorsJean L Whittingham, Isabel Leal, Corinne Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Targeting MYCN-Driven Transcription By BET-Bromodomain InhibitionAnton Henssen, Kristina Althoff, Andrea Odersky, et al.
Molecular Cell|February 20, 2021
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> T cellsHelen Loo Yau, Emma Bell, Ilias Ettayebi, et al.
Nature Cancer|February 19, 2026
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detectionYong Zeng, Dor D Abelman, Althaf Singhawansa, et al.
Nature Cancer|April 28, 2022
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Andrés F Flórez, Sina Kreth, et al.
Nature|October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Falk Hertwig, Frederik Roels, et al.
Pageof 5